Tomomi Aoshika
Overview
Explore the profile of Tomomi Aoshika including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Ryuno Y, Abe T, Iino M, Saito S, Aoshika T, Oota T, et al.
Radiat Oncol
. 2022 Jul;
17(1):128.
PMID: 35854333
Background: This retrospective study was performed to evaluate the efficacy and toxicity of high-dose stereotactic body radiotherapy (SBRT) using a CyberKnife® for patients with stage I peripheral non-small cell lung...
12.
Miyata Y, Murakami N, Okuma K, Shimizu Y, Takahashi A, Kashihara T, et al.
Brachytherapy
. 2022 Jun;
21(5):647-657.
PMID: 35750619
Purpose: Pelvic sidewall recurrence after hysterectomy for uterine malignances has a poor prognosis, and the salvage therapy for this type of recurrence is still challenging. The purpose of this study...
13.
Murakami N, Watanabe M, Uno T, Sekii S, Tsujino K, Kasamatsu T, et al.
Jpn J Clin Oncol
. 2022 Apr;
52(8):859-868.
PMID: 35470390
Objective: This is the preliminary results of a multi-center prospective clinical trial evaluating the feasibility of the hybrid of intracavitary and interstitial brachytherapy for locally advanced cervical cancer. Methods: Patients...
14.
Murakami N, Ando K, Murata M, Murata K, Ohno T, Aoshika T, et al.
J Radiat Res
. 2022 Apr;
63(3):412-427.
PMID: 35446962
This study is an international multi-institutional retrospective study comparing the clinical outcomes between intracavitary brachytherapy (ICBT) and the hybrid of intracavitary and interstitial brachytherapy (HBT) for locally advanced cervical cancer...
15.
Takakusagi Y, Kano K, Shima S, Tsuchida K, Mizoguchi N, Katoh H, et al.
Anticancer Res
. 2022 Mar;
42(4):2095-2104.
PMID: 35347033
Background/aim: The standard of treatment for esophageal cancer with adjacent organ invasion (T4) has not been established. We retrospectively analyzed the clinical outcomes of radiotherapy (RT) in elderly and younger...
16.
Abe T, Ryuno Y, Iino M, Saito S, Aoshika T, Ohta T, et al.
Jpn J Clin Oncol
. 2021 Sep;
51(12):1723-1728.
PMID: 34580722
Objective: Optimal dose-fractionation regimen of stereotactic body radiotherapy for peripheral early-stage non-small cell lung cancer remains unclear. We retrospectively investigated outcomes of stereotactic body radiotherapy using CyberKnife at 54 Gy...
17.
Murakami N, Ando K, Murata M, Murata K, Ohno T, Aoshika T, et al.
Gynecol Oncol
. 2021 Jul;
163(1):105-109.
PMID: 34294413
Objective: The majority of uterine cervical cancer is known to be related to human papillomavirus (HPV), and HPV-related tumors are known to be radio-sensitive. In the management of HPV-related oropharyngeal...
18.
Abe T, Iino M, Saito S, Aoshika T, Ryuno Y, Ohta T, et al.
J Radiat Res
. 2021 Jul;
62(5):894-900.
PMID: 34260719
The feasibility of intensity modulated radiotherapy (IMRT) with involved field radiotherapy (IFRT) for Japanese patients with locally advanced non-small cell lung cancer (LA-NSCLC) remains unclear. Here we reviewed our initial...
19.
Hirai R, Ohkubo Y, Igari M, Kumazaki Y, Aoshika T, Ryuno Y, et al.
In Vivo
. 2021 Jun;
35(4):2433-2437.
PMID: 34182527
Background/aim: Positional uncertainty in spinal stereotactic body radiotherapy (SBRT) may cause fatal error, therefore, we investigated the intra-fractional spinal motion during SBRT and its time dependency. Patients And Methods: Thirty-one...
20.
Saito S, Abe T, Iino M, Aoshika T, Ryuno Y, Ohta T, et al.
J Radiat Res
. 2021 Jun;
62(4):669-675.
PMID: 34121123
The aim of this study is to analyze the incidence and risk factors for pneumonitis when immune checkpoint inhibitors (ICIs) are combined with palliative thoracic radiotherapy (RT) for lung cancer....